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Abstract
Background—The Explorer Minimally Invasive Liver (MIL) system uses imaging to create a 3-
dimensional model of the liver. Intraoperatively, the system displays the position of instruments 
relative to the virtual liver. A prospective clinical study compared it with intraoperative ultrasound 
(iUS) in laparoscopic liver ablations.
Methods—Patients undergoing ablations were accrued from 2 clinical sites. During the 
procedures, probes were positioned in the standard fashion using iUS. The position was 
synchronously recorded using the Explorer system. The distances from the probe tip to the tumor 
boundary and center were measured on the ultrasound image and in the corresponding virtual 
image captured by the Explorer system.
Results—Data were obtained on the placement of 47 ablation probes during 27 procedures. The 
absolute difference between iUS and the Explorer system for the probe tip to tumor boundary 
distance was 5.5 ± 5.6 mm, not a statistically significant difference. The absolute difference for 
probe tip to tumor center distance was 8.6 ± 7.0 mm, not statistically different from 5 mm.
Discussion—The initial clinical experience with the Explorer MIL system shows a strong 
correlation with iUS for the positioning of ablation probes. The Explorer MIL system is a 
promising tool to provide supplemental guidance information during laparoscopic liver ablation 
procedures.
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Introduction
Three-dimensional (3D) image-guidance systems use preoperative imaging to create a 3D 
virtual model of organs. Intraoperatively, the systems track instruments and display their 
position relative to the organ and any structures of interest. The use of these systems for 
open hepatic resection and ablation procedures has been documented in the literature.1,2 
With increasing comorbidities associated with select patient populations (eg, cirrhosis) there 
has been an evolution of minimally invasive approaches to treat hepatic tumors.3–6 
Laparoscopic procedures require improved visualization to compensate for the lack of tactile 
feedback and these procedures could benefit from the utilization of image-guidance 
technology. Currently, the majority of operative hepatic ablation procedures are performed 
using intraoperative ultrasound (iUS), which requires considerable expertise and training. 
The incorporation of 3D image-guidance is a potentially valuable adjunct. One area in 
particular where this technology could be useful is in the targeting of lesions in cirrhotic 
patients where the quality of iUS imaging is severely compromised by the parenchymal 
changes throughout the liver.7
The Explorer Minimally Invasive Liver (MIL) system (Pathfinder Technologies, Nashville, 
TN) is an experimental 3D image-guidance system intended to be used in conjunction with 
iUS during laparoscopic liver ablations. The system consists of several components. The 
Scout Liver planning software (Pathfinder Technologies, Nashville, TN) generates 3D 
anatomical models of the liver, vessels, and tumors from preoperative computed tomography 
(CT) or magnetic resonance imaging (MRI) scans. The tracking system cart has a monitor, 
for displaying preoperative CT or MRI images and the 3D virtual models of the liver; an 
infrared light source; and a pair of infrared cameras for optical tracking of the Pathfinder 
Tracer arrays, described below. The tracked laparoscopic stylus is a calibrated instrument 
that is used to synchronize the position of the liver with the virtual model, a process called 
registration. Finally, Pathfinder Tracer arrays are adapters that can be attached to different 
ablation probes. The arrays reflect infrared light in a predetermined pattern that can be seen 
by the cameras and used to determine the position and configuration of the attached ablation 
probe. A schematic of the device hardware and software interface are shown in Figure 1.
As a first step toward the use of the Explorer MIL system during laparoscopic ablation 
procedures, this prospective clinical study compares the MIL system with iUS. During the 
performance of laparoscopic liver ablations, the probes were placed in the standard fashion 
using iUS. Just prior to initiating the ablation, the position of the probe was recorded using 
the Explorer MIL system. The purpose of the study was to compare the difference between 
the measurements made using the Explorer MIL system and those made using iUS.
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From November 2010 to February 2012, subjects undergoing laparoscopic ablation 
procedures (N = 27) were accrued at Providence Portland Medical Center in Portland, 
Oregon and the University of North Carolina Hospitals in Chapel Hill, North Carolina. The 
demographics of the included patients are summarized in Table 1. Ablations were performed 
using either the Angiodynamics StarBurst Xli-enhanced radiofrequency ablation (RFA) 
system or the Coviden Evident microwave ablation (MWA) system based on surgeon/center 
practice. Images and schematics of these 2 ablation systems are shown in Figure 2.
Presurgical Planning
Prior to performing the laparoscopic ablation procedure, the preoperative surgical planning 
software (Scout Liver) was used to generate 3D models of the liver, tumors, and vascular 
structures. Standard anatomical features were highlighted on the liver surface for use in the 
intraoperative registration process.
Surgical Procedure
The laparoscopic ablation procedures were performed per institutional protocol with one 
modification. Immediately prior to the placement of the ablation probe, a Pathfinder 
registration was performed. Registration is the synchronization of the liver position with the 
3D virtual model and involves tracing preselected anatomical features on the surface of the 
liver with the tracked laparoscopic stylus (Figure 1).8 The surgeon then qualitatively 
evaluated the registration accuracy by moving the stylus over the liver surface and/or 
touching anatomical landmarks to verify that the position corresponded with that seen on the 
virtual model.
The ablation probe, with the attached Pathfinder Tracer array, was then positioned using iUS 
guidance. To be clear, the Explorer MIL system was not used to assist in the placement of 
the probe. Immediately prior to the initiation of ablation, the location and trajectory of the 
ablation probe were recorded using the Explorer MIL system. In addition, iUS images 
showing the final probe placement were obtained. A screenshot of the Explorer MIL system 
display immediately prior to recording the ablation probe location is shown in Figure 3. In 
cases where multiple tumors were treated, data were collected for each ablation probe 
placement.
Postprocedure Analysis and Statistical Considerations
Data analysis acquired in the clinical evaluation of the Explorer MIL system was performed 
by comparing guidance information obtained from the system to iUS. Two measurements 
were used to compare the 2 modalities: (a) the Euclidean distance* between the tip of the 
ablation probe and the center of the tumor and (b) the closest point distance between the 
probe tip and the tumor boundary. An example of the distance measurements obtained from 
the 2 modalities is shown in Figure 4.
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Descriptive statistics, including means, standard deviations, medians, confidence intervals, 
and ranges were calculated using the measurements obtained from both modalities. 
Statistical comparison was performed with paired t tests or the Wilcoxon signed rank test 
depending on how well the data met the corresponding assumptions. In cases where it was 
unclear whether the assumptions were met, both parametric and nonparametric tests were 
performed.
Results
A summary of the data analysis comparing the Explorer MIL system with iUS is shown in 
Table 2. To more accurately represent the relationship between the tip of the ablation probe 
and the tumor boundary, the distance was assigned a positive value if the tip of the probe 
was located outside the tumor and a negative value if the tip was located inside the tumor. 
The absolute difference between the distance measurements made for the 2 modalities were 
used to calculate the statistical parameters reported in the summary.
The results of the paired statistical tests performed for the measurements made with the 2 
modalities are shown in Table 3. Given that the tip to tumor boundary data did not pass the 
normality test, the statistical comparison was performed using a Wilcoxon signed rank test 
where the median difference between the populations was hypothesized to be 0 mm. The 
results of the Wilcoxon signed rank test indicate that there is no statistically significant 
difference between the instrument tip to tumor boundary measurements made using the 
Explorer MIL system and iUS. The paired t test was used for comparison of the tip-to-tumor 
center data since they were normally distributed. When the difference in means was 
hypothesized to be 0 mm, there was a statistically significant difference between the tip-to-
center distance measurements obtained from the 2 modalities. However, when the difference 
in means was hypothesized to be 5 mm, the paired t test did not find a statistically 
significant difference between the tip-to-center measurements. Given that the data for the tip 
to center distance measurements passed normality tests, a power calculation can be 
performed for the statistical test. The standard deviation for the ablation tip-to-lesion center 
distance measurements indicates that the paired t test was capable of detecting a difference 
of 3.8 mm with a power of 80% and significance of 95% (α = .05).
To determine if tumor location affected the accuracy of the Explorer MIL system, the data 
were also examined based on Couinaud segment. These data are summarized in Table 4. 
Comparing the 2 modalities, there was no statistically significant difference (P = .212) 
between the tip-to-boundary distances as a function of Couinaud segment. Since the tip-to-
boundary measurements were not normally distributed, they were compared using the 
Kruskal–Wallis 1-way analysis of variance (ANOVA) on ranks where the median difference 
between the groups was hypothesized to be 0 mm.
Similarly, there was no statistically significant difference between the tip-to-center distances 
as a function of Couinaud segment (P = .105). This was determined using 1-way ANOVA, 
where the hypothesized mean difference between the groups was 0 mm, based on the results 
of the normality (P = .274) and equal variance (P = .056) tests. Considering that the equality 
of variance assumption was somewhat questionable, an additional statistical comparison was 
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performed using the Kruskal–Wallis 1-way ANOVA on ranks where the hypothesized 
median difference between the group was 0 mm. This analysis also showed no statistically 
significant difference between the Angiodynamics StarBurst Xli-enhanced RFA system and 
the Covidien Evident MWA system (P = .105).
Discussion
Analysis of the data collected in the clinical evaluation of the Explorer MIL system indicates 
that the guidance information provided by the system correlates well with information 
provided by iUS. Specifically, there was no statistically significant difference between the 2 
modalities when measuring the distance from the probe tip to the tumor boundary. 
Furthermore, the mean absolute difference in the measurements is within the clinically 
accepted range of accuracy (5 mm to 1 cm) identified in the literature for laparoscopic 
ablation procedures.9–11 There was also no statistically significant difference found between 
the tip-to-center distance measurements made for the 2 guidance modalities, when a 
hypothesized mean difference of 5 mm is used in the statistical comparison. However, the 
mean absolute difference in the tip-to-center distance measurements was 8.57 mm, which is 
greater than 5 mm, the lower end of the clinically acceptable range. It should be noted that 
there is more error associated with estimating the location of the tumor center using 2D iUS 
images.
While there is a correlation between the data acquired from the 2 modalities, it is important 
to recall that a number of sources of confounding error exist. Because of the fact that the 
iUS image is 2D and the Explorer MIL system makes measurements in 3D, direct 
comparison of the 2 sets of distance measurements is complicated. Specifically, the tumor 
center and closest tumor boundary as identified on 2D iUS images may not correspond to 
those identified on the preoperative images used by the Explorer MIL system. Furthermore, 
the ability to accurately localize the tip of the ablation probe in the iUS image assumes that 
the probe is held directly “in-plane” with the iUS transducer. If this is not done, the tip 
identified in the iUS image may not correspond to the true tip of the probe. It should be 
noted that overall the tip-to-tumor boundary distance is subject to less bias from these 
confounding error sources.
In addition to the difficulties in making direct comparisons between the measurements 
obtained from the 2 modalities, it should be kept in mind that the distance measurements 
made from the tip of the ablation probe to the center of the target tumor should not be 
interpreted as a measure of the accuracy. In most cases, the tip of the ablation probe is not 
intended to be placed at the center of the target lesion.12 In procedures involving the 
Covidien Evident MWA system, multiple antennae are often placed around the periphery of 
the target tumor to produce the desired ablation zone. When using the Angiodynamics 
StarBurst Xli-enhanced RFA system, the goal is to place the tip of the probe in line with the 
center of the tumor but approximately 5 mm from the tumor boundary in order to completely 
ablate the tumor once the tines are deployed (see Figure 2). Given the extreme variability in 
the intended placement of the tip of the ablation probe it is difficult to accurately determine 
an absolute error in probe placement based on distances to the target tumor boundary or 
Hammill et al. Page 5













center. Given these limitations, the direct distance measurements depicted in Figure 4 
represent the best comparison possible from the data acquired in the clinical setting.
In addition to the direct paired comparison of the distance measurements made from the 2 
guidance modalities, statistical comparisons were performed to evaluate the impact of lesion 
location. Evaluation of the data summarized in Table 4 indicates that there is no statistically 
significant difference between the measurements, when analyzed based on Couinaud 
segment location of the target tumor.
One of the biggest sources of potential error in the Explorer MIL system is flexing of the 
ablation probe. The system optically tracks the Pathfinder Tracer array attached to the 
handle of the instrument and based on this calculates where the tip of the instrument is 
predicted to be. Any deflection of the probe has the potential to create an error in the 
calculated probe tip position. Presumably this error would be less in Covidien Evident 
MWA system, which is a stiffer probe; however, in this series there was no statistically 
significant impact based on the ablation technology used.
In conclusion, the initial clinical experience with the Explorer MIL system suggests that the 
device is a promising tool in providing supplemental 3D guidance information during 
laparoscopic ablation procedures. Although the comparison with iUS was limited in some 
respects, the guidance information provided by the Explorer MIL device is statistically 
equivalent with that provided by laparoscopic iUS. Future work will focus on the 
incorporation of tracked laparoscopic iUS within the system similar to that reported by 
Kingham et al2 for open hepatic procedures.
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Image of the Explorer Minimally Invasive Liver (MIL) device with the tracking system cart 
and the tracked laparoscopic stylus (left). Screen captures of the guidance system (top right) 
and the corresponding laparoscopic view (bottom right) show the stylus being used; it is 
shown as green in the virtual model.
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Images of the Angiodynamics StarBurst Xli-Enhanced radiofrequency ablation system (left) 
and the Covidien Evident microwave ablation system (right) along with the manufacturer 
specifications of the predicted ablation zones.
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Screen capture of the software display of the Explorer Minimally Invasive Liver system 
during a laparoscopic ablation procedure. The display shows tracked location of the tip of 
the ablation probe on the sagittal (top left quadrant) and axial (bottom left quadrant) slice of 
the magnetic resonance image. In the bottom right quadrant, the 3-dimensional virtual model 
is shown with the tumor in brown and the ablation probe in green. The streaming video feed 
from the intraoperative ultrasound is displayed in the top right quadrant.
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Example of the measurements obtained from intraoperative ultrasound (iUS; left) and 
Explorer Minimally Invasive Liver (MIL) system (right) are shown. The distance from the 
probe tip to the tumor boundary (yellow arrow) and the distance from the probe tip to tumor 
center (white arrow) are illustrated. In the iUS image, the tumor center is identified by a blue 
star. The virtual model from the Explorer MIL system shows the recorded location of the 
probe tip (red sphere), the tumor being targeted (gray), the tumor center (blue sphere), and 
projected ablation zone (orange).
Hammill et al. Page 11

























Hammill et al. Page 12
Table 1




  Male 23
  Female 4
Age in years 60.1 ± 6.9
Preoperative imaging
  Computed tomography 11
  Magnetic resonance 16
Total lesions 31
Lesion location
  I 0
  II 6
  III 0
  IV 7
  V 3
  VI 3
  VII 5
  VIII 7
Ablation modality
  Microwave 16
  Radiofrequency 15
Pathology
  Hepatocellular carcinoma 22
  Metastatic colorectal carcinoma 8
  Other metastases 1
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Table 3
Summary of the Statistical Analysis Performed to Compare the Distance Measurements Made Using iUS and 
the Explorer Minimally Invasive Liver System.
Normality Paired t Test/WSR Test
Tip–boundary distance (WSR test, Mdiff = 0 mm) Failed (P < .05) Accept H0 (P = .06)
Tip–center distance (t test, μdiff = 0 mm) Passed (P = .71) Reject H0 (P < .001)
Tip–center distance (t test, μdiff = 5 mm) Passed (P = .71) Accept H0 (P = .29)
Abbreviations: iUS, intraoperative ultrasound; μdiff, the assumed difference in means; Mdiff, the assumed difference in medians; WSR test, 
Wilcoxon signed rank test.













Hammill et al. Page 15
Table 4
Summary of the Absolute Differences Between iUS and the Explorer Minimally Invasive Liver System 
Analyzed by Couinaud Segment.
Couinaud Segment Tip–Boundary Difference
(mm, μ ± 95% CI)
Tip–Center Difference
(mm, μ ± 95% CI)
2 (N = 8) 2.11 ± 1.29 4.83 ± 2.41
3 (N = 0) N/A N/A
4 (N = 10) 5.83 ± 3.29 7.42 ± 3.51
5 (N = 4) 2.99 ± 1.54 5.44 ± 3.54
6 (N = 6) 8.20 ± 6.21 14.62 ± 9.12
7 (N = 7) 5.91 ± 5.02 11.16 ± 5.40
8 (N = 11) 6.72 ± 3.69 9.26 ± 3.69
Abbreviations: iUS, intraoperative ultrasound; CI, confidence interval; N/A, not applicable.
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